Endonovo Therapeutics (QB) Stock Price

-0.00517 (-10.34%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Endonovo Therapeutics Inc (QB) ENDV OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.00517 -10.34% 0.04483 13:28:18
Open Price Low Price High Price Close Price Previous Close
0.052 0.0412 0.052 0.05
Bid Price Ask Price Spread News
0.0415 0.046 0.0045 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
17 175,786 $ 0.042684 $ 7,503 91,831 0.0011 - 3.90
Last Trade Time Type Quantity Stock Price Currency
13:27:32 12,952 $ 0.04483 USD

Endonovo Therapeutics (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 753.10k 17.02M 8.99M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
5.89k $ - 0.00% - -

more financials information »

Endonovo Therapeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ENDV Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.061350.06750.04120.0525952324,578-0.01652-26.93%
1 Month0.08650.0950.04120.0600017159,972-0.04167-48.17%
3 Months0.1050.1250.04120.073919295,417-0.06017-57.3%
6 Months0.13510.16950.0140.0971405105,188-0.09027-66.82%
1 Year0.00263.900.00110.0621061528,0820.042231,624.23%
3 Years0.060753.900.00110.0251472,221,879-0.01592-26.21%
5 Years0.12453.900.00110.0374361,813,258-0.07967-63.99%

Endonovo Therapeutics (QB) Description

Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders. Endonovo's Electroceutical Therapy is FDA-Cleared for the palliative treatment of pain and post-surgical edema (swelling) and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Endonovo's Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. The Company's current pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders, including ischemic heart disease, acute concussions, post-concussion syndrome, traumatic brain injury (TBI) and multiple sclerosis.

Your Recent History
Endonovo T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.